Boston Scientific (BSX) FCF Payout Ratio (2020 - 2023)

Boston Scientific has disclosed FCF Payout Ratio across 4 years of filings, most recently posting 0.03 for Q2 2023.

• FCF Payout Ratio for Q2 2023 came in at 0.03, down 60.78% year-over-year; the trailing twelve-month figure through Mar 2024 was 0.01 (down 82.07% YoY), and the FY2023 annual result was 0.02, down 73.35% from the prior year.
• FCF Payout Ratio came in at 0.03 for Q2 2023 at Boston Scientific, down from 0.18 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 0.18 in Q1 2023 to a low of 0.08 in Q1 2022.
• The 4-year median for FCF Payout Ratio is 0.03 (2020), against an average of 0.04.
• Across the five-year window, FCF Payout Ratio tumbled 216.76% in 2022 and soared 326.58% in 2023, its largest moves.
• Boston Scientific's FCF Payout Ratio stood at 0.03 in 2020, then surged by 125.13% to 0.06 in 2021, then sank by 64.37% to 0.02 in 2022, then gained by 24.42% to 0.03 in 2023.
• The last three FCF Payout Ratio figures came in at 0.03 (Q2 2023), 0.18 (Q1 2023), and 0.02 (Q4 2022), per Business Quant data.